𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Activity of all-trans-retinoic acid in a case of central nervous system extramedullary relapse of acute promyelocytic leukemia

✍ Scribed by Francesca Patriarca; Carla Filì; Antonella Geromin; Alessandra Sperotto; Simonetta Prosdocimo; Renato Fanin

Book ID
114423122
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
100 KB
Volume
68
Category
Article
ISSN
0902-4441

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacology of all-trans-retinoic acid
Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia
✍ Lanvers, Claudia ;Reinhardt, Dirk ;Dübbers, Angelika ;Wagner-Bohn, Alexandra ;Cr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 1 views

## Abstract ## Background Due to severe side effects in virtually all children treated with a standard dose of 45 mg/m^2^/day all‐__trans__‐retinoic acid (ATRA) for acute promyelocytic leukemia (APL) the AML‐BFM study group reduced the dosage to 25 mg/m^2^/day. For the lack of data on the use of A

All-trans retinoic acid followed by chem
All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia
✍ Jorge E. Cortes; Hagop Kantarjian; Susan O'Brien; L. E. Robertson; Charles Kolle 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

Background. All-trans retinoic acid (ATRA) is effective in the treatment of relapsed or refractory acute promyelocytic leukemia (APL), but relapse is the rule if response is unmaintained. Methods. Seventeen patients with APL were salvaged with ATRA at a dosage of 50 mg/mz/day for 3 months or until